- Home
- BSET vs BDTX Comparison
BSET vs BDTX Comparison
Compare BSET & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSET | BDTX |
|---|---|---|
| Founded | 1902 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 148.1M |
| IPO Year | 1987 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BSET | BDTX |
|---|---|---|
| Price | $15.12 | $2.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.40 |
| AVG Volume (30 Days) | 10.9K | ★ 938.7K |
| Earning Date | 02-04-2026 | 03-05-2026 |
| Dividend Yield | ★ 5.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.90 | 0.38 |
| Revenue | ★ $330,953,000.00 | $70,000,000.00 |
| Revenue This Year | $3.11 | N/A |
| Revenue Next Year | $3.00 | N/A |
| P/E Ratio | $17.03 | ★ $6.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.63 | $1.20 |
| 52 Week High | $19.75 | $4.94 |
Technical Indicators
Market Signals| Indicator | BSET | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 32.51 | 47.67 |
| Support Level | $16.27 | $2.49 |
| Resistance Level | $17.41 | $2.70 |
| Average True Range (ATR) | 0.61 | 0.15 |
| MACD | -0.20 | 0.02 |
| Stochastic Oscillator | 12.93 | 53.85 |
Price Performance
Historical ComparisonAbout BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.